leisure time -WSS

leisure time

author：Wikipedia 2025-09-30 16:28:40 - browse：13

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Sanofi says it has 12 blockbusters on the way. Will investors believe it?

WSS

Illumina names Agilent executive as new CEO

Pregnancy discrimination could be enabled by AI

Why Novartis is changing the name of its research labs

Americans' trust in science, scientist continues decline: Report

Teach medical students about patients with intellectual disabilities

What causes an itch? Researchers may have solved the mystery

hotspot

leisure time

focus

Medical leaders decry Supreme Court decision on affirmative action

What American doctors can learn from their Israeli counterparts

Malaria cases in Florida and Texas: Here’s what you need to know

Radiology is caught between AI's potential and concern for patients

What does generative AI mean for health care? We asked experts

Humana sues Biden admin over Medicare Advantage audit rule

Medical records are filled with copy

Pfizer plans to depart BIO

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Listen: Biogen's potential pivot, & Illumina's next chapter

leisure time

Weighted lottery helped low

SCOTUS to consider access to abortion pill mifepristone

What causes an itch? Researchers may have solved the mystery

How generative AI is inspiring dreams of a health data revolution

The 10 drugs up first for Medicare price negotiation

Americans' trust in science, scientist continues decline: Report

knowledge

hotspot

hotspot

focus